China Resources Pharmaceutical Group Limited: all 69 studies

Page 1 of 1. Open to participants first (23), then studies with results posted, then the rest; newest registration first within each.

• Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUreRecruitingNCT07687186Phase 3
• TSL2109 Capsules in Advanced Solid Tumor Patients: Safety, Tolerability, PK and Preliminary EfficacyRecruitingNCT07514065Phase 1
• A Study of the Effectiveness and Safety of JS1-1-01 Tablet in Patients With Moderate to Severe DepressionNot yet recruitingNCT07485595Phase 2/3
• A Study of B2065 in Patients With Acute Ischemic StrokeRecruitingNCT07371624Phase 1/2
• A Clinical Trial of P134 Cells in Recurrent GlioblastomaRecruitingNCT07318818Phase 1/2
• A Clinical Trial Evaluating the Efficacy and Safety of Sanhuang Jingshiming Pills in the Treatment of nAMDNot yet recruitingNCT07269769Phase 3
• A Phase I/II Clinical Trial of Intramyocardial Injection of HucMSCs for the Treatment of Chronic Heart FailureRecruitingNCT07265349Phase 1/2
• a Safety, Tolerability, and Pharmacokinetic Trial of Multiple Subcutaneous Injections of B1344 Injection in Patients With Nonalcoholic Fatty Liver Disease（NAFLD）RecruitingNCT07128797Phase 1
• A Multicenter, Open Phase IIb Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Colorectal CancerNot yet recruitingNCT06838546Phase 2
• Phase III Trial of Susu Zhike Granules in Children With Cold-cough Syndrome for Acute Cough TreatmentNot yet recruitingNCT06773117Phase 3
• Efficacy and Safety of Changkang Granules in the Treatment of Irritable Bowel Syndrome With Predominant Diarrhea (Liver qi Affecting the Spleen Pattern)Not yet recruitingNCT06753890Phase 3
• A Multicenter, Open-label Phase IIa Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Malignant Solid TumorsNot yet recruitingNCT06724263Phase 2
• A Study of the Efficacy and Safety of Antiwei Granules in the Treatment of Common ColdRecruitingNCT06697886Phase 3
• A Study of Lianxiaxiaopi Granules in the Treatment of Postprandial Distress SyndromeRecruitingNCT06696261Phase 3
• Efficacy and Safety of Xiangjurupining Capsule for Hyperplasia of Mammary GlandsRecruitingNCT06685978Phase 3
• Efficacy and Safety of Jia Shen Tablets in Chronic Heart FailureNot yet recruitingNCT06669169Phase 2
• Pharmacokinetic and Pharmacodynamic of Jia Shen Tablets in Chronic Heart FailureRecruitingNCT06348498Phase 1
• Efficacy and Safety of Jiuweihuaban Pill for Treating Plaque PsoriasisRecruitingNCT06058546Phase 2
• A Study of Comparing Overall Improvement of Patients With Spondyloarthritis Treated With Jitongning Tablets and PlaceboRecruitingNCT06000956Phase 3
• A Study of B1962, a PD-L1/VEGF Bispecific Antibody Fusion Protein, for Advanced Solid TumorsNot yet recruitingNCT05650385Phase 1
• HuHuangLianzonggan Capsule in Subjects With Nonalcoholic Steatohepatitis: a Phase 2 tRial(HHL-HEPAR)RecruitingNCT05632861Phase 2
• A Study to Evaluate the Efficacy and Safety of TSL-1502 Capsules in Breast Cancer Patients With Germline BRCA MutationsRecruitingNCT05420779Phase 2
• Outcome Research to Confirm the Anti-anginal Effect of T89 in Patients With Stable AnginaRecruitingNCT03789552Phase 3
• Dose-Escalate Study to Investigate the Safety and Tolerability of T89 in JapaneseCompletedNCT01679028Phase 1Results posted
• A Study of the Effectiveness and Safety of JS1-1-01 in Patients With Moderate to Severe DepressionCompletedNCT06259526Phase 2
• A Study of STRO-002 in Chinese Adults With Epithelial Ovarian Cancer and Other Advanced Malignant Solid TumorsCompletedNCT06238687Phase 1/2
• A Study to Evaluate Efficacy and Safety of Qingzhu Granules in the Treatment of Acute Gouty ArthritisCompletedNCT06068478Phase 3
• A Study of the Safety and Efficacy of Pimavanserin in Patients With Parkinson's Disease PsychosisCompletedNCT06068465Phase 3
• Efficacy and Safety of QiShen YiQi Dripping Pills in the Treatment of Diabetic Kidney Disease (Syndrome of Qi Deficiency With Blood Stasis)CompletedNCT06006689Phase 2
• rhPro-UK in Acute Ischaemic Stroke Within 4.5 Hours of Stroke Onset Trial 2(PROST-2)CompletedNCT05700591Phase 3
• A Study of the Safety,Tolerability,and Pharmacokinetics of Multiple-Ascending Dose JS1-1-01 in Healty Subjects.CompletedNCT05656274Phase 1
• A Trial to Evaluate the Safety Tolerability and Pharmacokinetics of B1344 by Subcutaneous Injection in Healthy SubjectsStatus unknownNCT05655221Phase 1
• A Trial of CRB4101 in Healthy SubjectsStatus unknownNCT05641181Phase 1
• A Real World Study of the Treatment of Gastric Adenocarcinoma With HuachansuStatus unknownNCT05249244
• A Clinical Study to Evaluate the Safety and Efficacy of T92 in Pediatric Patients With Tourette SyndromeStatus unknownNCT05188274Not applicable
• Evaluate the Efficacy, Safety and Tolerability of TSUPPORT for Adults With Tourette SyndromeStatus unknownNCT05183594Not applicable
• Exploratory Study on Dosage of Qizhi Weitong Granules in the Treatment of Irritable Bowel Syndrome （IBS)Status unknownNCT05113888Phase 2
• Jinfukang Oral Liquid Combined With Chemotherapy for Treating Driver Gene-negative Advanced NSCLCStatus unknownNCT05098990Phase 4
• Safety and Efficacy of T89 in the Prevention and Treatment of Adults With Acute Mountain Sickness (AMS)CompletedNCT04993729Phase 3
• Efficacy and Safety of QiShen YiQi Dripping Pills in Chronic Heart FailureCompletedNCT04983043Phase 2
• Efficacy and Safety of Qishenyiqi Dripping Pills for Treating Chronic Heart Failure With Preserved Ejection FractionCompletedNCT04944706Phase 2
• Efficacy and Safety of Yuxuebi Tablet in Treating Night Pain of Ankylosing Spondylitis (AS).Status unknownNCT04934059Phase 4
• Expanded Access to T89 for Treatment Use in Intermediate-size Patients Population With COVID-19No longer availableNCT04646031
• Efficacy and Safety of Changkang Granule in the Treatment of Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)CompletedNCT04492787Phase 2
• A Phase Ⅱ Clinical Study of Sanhuangjingshimingwan in Wet( Neovascular)Age-related Macular Degeneration(wAMD) SubjectsCompletedNCT04486963Phase 2
• A Study of Qishenyiqi Dripping Pills in Healthy ParticipantsCompletedNCT04471298Phase 1
• Efficacy and Safety of Susu Zhike Granules for Treating Acute Cough Due to Common Cold With Cold-cough Syndrome in ChildrenCompletedNCT04457011Phase 2
• The Effect of T89 on Improving Oxygen Saturation and Clinical Symptoms in Patients With COVID-19WithdrawnNCT04285190Not applicable
• A Study of Xiangjurupining Capsule in the Treatment of Hyperplasia of Breast (Liver Stagnation and Phlegm Coagulation)CompletedNCT04229706Phase 2
• Safety, Tolerability and Pharmacokinetics Characteristics of Recombinant Oncolytic Vaccinia Virus Injection T601 as a Single Drug or in Combination With Oral Flucytosine (5-FC), in Patients With Advanced Malignant Solid TumorsStatus unknownNCT04226066Phase 1/2
• Safety and Efficacy of Therapeutic Hepatitis B Adenovirus Injection (T101) Combined With Nucleoside (Acid) Analogues in Chronic Hepatitis B PatientsStatus unknownNCT04189276Phase 2
• Safety and Efficacy of Therapeutic Hepatitis B Adenovirus Injection (T101) in Chronic Hepatitis B PatientsCompletedNCT04168333Phase 1
• A Study to Evaluate the Tolerability and Pharmacokinetics of Jiashen Tablets in Healthy SubjectsCompletedNCT04164290Phase 1
• Study of Jitongning Tablet to Treat SpondyloarthritisCompletedNCT03932019Phase 2
• Effects of Deepure(Pu-erh Tea Extract) on Glycemic ControlStatus unknownNCT03613688Not applicable
• Thrombolysis With rhPro-UK in 4.5-6 Hours After Acute Ischemic Stroke in a Double-blinded,Controlled TrialCompletedNCT03578822Phase 3
• Safety and Efficacy of T89 in Prevention and Treatment of Adults With Acute Mountain Sickness (AMS)CompletedNCT03552263Phase 2
• Study of rhPro-UK in Patients With Acute Ischaemic Stroke in 4.5 Hours After Stroke Onset(PROST)CompletedNCT03541668Phase 3
• Study of Compound Danshen Dripping Pills to Treat Acute Mountain SicknessCompletedNCT03270787Phase 1/2
• A Study on the Mifepristone Tablets in the Treatment of Symptomatic Uterine Fibroids With Safety and EfficacyTerminatedNCT03210324Phase 4
• A Trial in Recombinant Human Prourokinase to Treat Acute Pulmonary EmbolismCompletedNCT03108833Phase 2
• A Study of Ginsenoside H Dripping Pills for Advanced Non-Small Cell Lung Cancer (NSCLC)Status unknownNCT02714608Phase 2
• Phase III Study of Compound Danshen Dripping Pills to Treat Diabetic RetinopathyStatus unknownNCT02388984Phase 3
• A Study to Evaluate the Efficacy and Safety of Shenfu Zhusheye in Patients With Acute Heart FailureCompletedNCT02135835Phase 4
• Phase III Trial of Dantonic® (T89) Capsule to Prevent and Treat Stable AnginaCompletedNCT01659580Phase 3
• Phase III Study of 5LGr to Treat Tic DisorderCompletedNCT01501695Phase 3
• A Study to Evaluate the Effect of T89(Dantonic®)on Steady-State Pharmacodynamics of WarfarinCompletedNCT01475279Phase 1
• A Study To Evaluate The Effect of T89(Dantonic®)On P450 EnzymesCompletedNCT01473888Phase 1
• Phase II Multi-Center Study of T89 to Treat Chronic Stable AnginaCompletedNCT00797953Phase 2

← China Resources Pharmaceutical Group Limited overview and focus areas